These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29660352)

  • 21. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the Strong Hearts program after a major cardiovascular event in patients with cardiovascular disease.
    Murphy BE; Card PD; Ramirez-Kelly L; Xaysuda AM; Heidel RE
    J Osteopath Med; 2023 Jun; 123(6):279-285. PubMed ID: 36958944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with high baseline exercise capacity benefit from cardiac rehabilitation and exercise training programs.
    Lavie CJ; Milani RV
    Am Heart J; 1994 Dec; 128(6 Pt 1):1105-9. PubMed ID: 7985590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Which Amount of BMI-SDS Reduction Is Necessary to Improve Cardiovascular Risk Factors in Overweight Children?
    Reinehr T; Lass N; Toschke C; Rothermel J; Lanzinger S; Holl RW
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3171-9. PubMed ID: 27285295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A middle school intervention to improve health behaviors and reduce cardiac risk factors.
    Eagle TF; Gurm R; Smith CA; Corriveau N; DuRussell-Weston J; Palma-Davis L; Aaronson S; Goldberg C; Kline-Rogers E; Cotts T; Jackson EA; Eagle KA
    Am J Med; 2013 Oct; 126(10):903-8. PubMed ID: 23932159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical profile and outcomes of diabetic and nondiabetic patients in cardiac rehabilitation.
    Hindman L; Falko JM; LaLonde M; Snow R; Caulin-Glaser T
    Am Heart J; 2005 Nov; 150(5):1046-51. PubMed ID: 16290994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interdisciplinary cardiovascular and neurologic outpatient rehabilitation in patients surviving transient ischemic attack or stroke with minor or no residual deficits.
    Kamm CP; Schmid JP; Müri RM; Mattle HP; Eser P; Saner H
    Arch Phys Med Rehabil; 2014 Apr; 95(4):656-62. PubMed ID: 24184308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex differences in cardiac rehabilitation.
    O'Farrell P; Murray J; Huston P; LeGrand C; Adamo K
    Can J Cardiol; 2000 Mar; 16(3):319-25. PubMed ID: 10744794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of duration in a cardiac rehabilitation program on coronary risk profile and health-related quality of life outcomes.
    Morrin L; Black S; Reid R
    J Cardiopulm Rehabil; 2000; 20(2):115-21. PubMed ID: 10763159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of multidisciplinary patient counselling in reducing cardiovascular disease risk factors through nonpharmacological intervention: results from the Healthy Heart Program.
    Simpson DR; Dixon BG; Bolli P;
    Can J Cardiol; 2004 Feb; 20(2):177-86. PubMed ID: 15010741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia.
    Reyna-Villasmil N; Bermúdez-Pirela V; Mengual-Moreno E; Arias N; Cano-Ponce C; Leal-Gonzalez E; Souki A; Inglett GE; Israili ZH; Hernández-Hernández R; Valasco M; Arraiz N
    Am J Ther; 2007; 14(2):203-12. PubMed ID: 17414591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction in C-reactive protein through cardiac rehabilitation and exercise training.
    Milani RV; Lavie CJ; Mehra MR
    J Am Coll Cardiol; 2004 Mar; 43(6):1056-61. PubMed ID: 15028366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes of risk factors in patients with coronary heart disease after in-patient rehabilitation].
    Küpper-Nybelen J; Rothenbacher D; Hahmann H; Wüsten B; Brenner H
    Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1525-30. PubMed ID: 12854061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicenter Study of Temporal Trends in the Achievement of Atherosclerotic Cardiovascular Disease Risk Factor Goals During Cardiac Rehabilitation.
    Gordon NF; Salmon RD; Sperling LS; Wright BS; Faircloth GC; Gordon TL; Berk MR; Rubenfire M; Franklin BA
    J Cardiopulm Rehabil Prev; 2017 Jan; 37(1):11-21. PubMed ID: 27798509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intake of bilberries (Vaccinium myrtillus L.) reduced risk factors for cardiovascular disease by inducing favorable changes in lipoprotein profiles.
    Habanova M; Saraiva JA; Haban M; Schwarzova M; Chlebo P; Predna L; Gažo J; Wyka J
    Nutr Res; 2016 Dec; 36(12):1415-1422. PubMed ID: 27993193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
    Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
    Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
    Velussi M
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.